References
- Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40:135–6.
- Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov. 2010; 9:719–27.
- Wiederhold NP, Patterson TF. What’s new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents. Curr Opin Infect Dis. 2015; 28:539–45.
- Abhinit M, Ghodke M, Pratima NA. Exploring potential of 4-thiazolidinone: a brief review. Int J Pharm Pharm Sci. 2009; 1:47–64.
- Zhou H, Wu S, Zhai S, Liu A, Sun Y, Li R, et al. Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. J Med Chem. 2008; 51:1242–51.
- Barreca ML, Chimirri A, De Luca L, Monforte AM, Monforte P, Rao A, et al. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett. 2001; 11:1793–6.
- Buvana C, Mahalaksmi A, Bijo M, Sukumar M. Synthesis of some thiazolidinone derivatives from indole 2-carboxylic acid and evaluation of its xanthine oxidase inhibitory and antioxidant activity. Int J ChemTech Res. 2011; 3:671–5.
- Gürsoy A, Terzioğlu N. Synthesis and isolation of new regioisomeric 4-thiazolidinones and their anticonvulsant activity. Turk J Chem. 2005; 29:247–54.
- Chavan A, Pai NR. Synthesis and antimicrobial screening of 5-aryliden-4-thiazolidinones. ARKIVOC. 2007; 16:148–55.
- Desai NC, Bhatt N, Kumar M, Makwana A. Synthesis, characterization and antimicrobial activity of some 3-(2-(1H-benzod imidazol-2-yl)phenyl)-2-arylthiazolidin-4-ones. Indian J Chem. 2011; 50B:941–5.
- Parekh HH, Parikh KA, Parikh AR. Synthesis of some 4-thiazolidinone derivatives as antitubercular agents. J Sci IR Iran. 2004; 15:143–8.
- Vicini P, Geronikaki A, Incerti M, Zani F, Dearden J, Hewitt M. 2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure–activity relationship. Bioorg Med Chem. 2008; 16:3714–24.
- Vinay V, Lakshika K. A review on antimicrobial activity of 4-thiazolidinone derivatives. Int J Pharm Pharm Sci. 2011; 1:17–27.
- Khafagy MM, Abd El-Wahab AHF, Eid FA, El-Agrody AM. Synthesis of halogen derivatives of benzo[h]chromene and benzo[a] anthracene with promising antimicrobial activities. Il Farmaco. 2002; 57:715–22.
- Miroslaw B, Plech T, Wujec M. Halogen bonding in the antibacterial 1,2,4-triazole-3-thione derivative – Spectroscopic properties, crystal structure and conformational analysis. J Mol Struct. 2015; 1083:187–93.
- Howe RA, Andrews JM. BSAC working party on susceptibility testing. BSAC standardized disc susceptibility testing method (version 11). J Antimicrob Chemother. 2012; 67:2783–4.
- MacGowan AP, Wise R. Establishing MIC breakpoints and interpretation of in vitro susceptibility tests. J Antimicrob Chemother. 2001; 48(Suppl S1):17–28.
- Montalbetti CAGN, Falque V. Amide bond formation and peptide coupling. Tetrahedron. 2005; 61:10827–52.
- Guo H, Xie F, Zhu M, Li Y, Yang Z, Wang X, et al. The synthesis of pteroyl-lys conjugates and its application as technetium-99m labeled radiotracer for folate receptor-positive tumor targeting. Bioorg Med Chem Lett. 2011; 21:2025–9.
- Shelar V, Telkar R, Venkataramana CHS. Synthesis and antimicrobial activity of some novel thiazolidinone derivatives. Der Pharmacia Lettre. 2010; 2:146–54.